These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 23419748)

  • 1. Loss of the major Type I arginine methyltransferase PRMT1 causes substrate scavenging by other PRMTs.
    Dhar S; Vemulapalli V; Patananan AN; Huang GL; Di Lorenzo A; Richard S; Comb MJ; Guo A; Clarke SG; Bedford MT
    Sci Rep; 2013; 3():1311. PubMed ID: 23419748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep Protein Methylation Profiling by Combined Chemical and Immunoaffinity Approaches Reveals Novel PRMT1 Targets.
    Hartel NG; Chew B; Qin J; Xu J; Graham NA
    Mol Cell Proteomics; 2019 Nov; 18(11):2149-2164. PubMed ID: 31451547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A remodeled protein arginine methyltransferase 1 (PRMT1) generates symmetric dimethylarginine.
    Gui S; Gathiaka S; Li J; Qu J; Acevedo O; Hevel JM
    J Biol Chem; 2014 Mar; 289(13):9320-7. PubMed ID: 24478314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding protein arginine methyltransferase 1 (PRMT1) product specificity from molecular dynamics.
    Gathiaka S; Boykin B; Cáceres T; Hevel JM; Acevedo O
    Bioorg Med Chem; 2016 Oct; 24(20):4949-4960. PubMed ID: 27545444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of human protein arginine N-methyltransferase 2: formation of monomethyl- and asymmetric dimethyl-arginine residues on histone H4.
    Lakowski TM; Frankel A
    Biochem J; 2009 Jun; 421(2):253-61. PubMed ID: 19405910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-methylarginine antibody generation using PEG linked GAR motifs as antigens.
    Wang Y; Person MD; Bedford MT
    Methods; 2022 Apr; 200():80-86. PubMed ID: 34107353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.
    Tsikas D; Bollenbach A; Hanff E; Kayacelebi AA
    Cardiovasc Diabetol; 2018 Jan; 17(1):1. PubMed ID: 29301528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRMT-5 converts monomethylarginines into symmetrical dimethylarginines in Caenorhabditis elegans.
    Kanou A; Kako K; Hirota K; Fukamizu A
    J Biochem; 2017 Feb; 161(2):231-235. PubMed ID: 28173048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational Study of Symmetric Methylation on Histone Arginine Catalyzed by Protein Arginine Methyltransferase PRMT5 through QM/MM MD and Free Energy Simulations.
    Yue Y; Chu Y; Guo H
    Molecules; 2015 May; 20(6):10032-46. PubMed ID: 26035101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Readers of histone methylarginine marks.
    Gayatri S; Bedford MT
    Biochim Biophys Acta; 2014 Aug; 1839(8):702-10. PubMed ID: 24583552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Monomethylarginine Proteomics Suggests that Protein Arginine Methyltransferase 1 (PRMT1) is a Significant Contributor to Arginine Monomethylation in
    Yakubu RR; Silmon de Monerri NC; Nieves E; Kim K; Weiss LM
    Mol Cell Proteomics; 2017 Apr; 16(4):567-580. PubMed ID: 28143887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient Kinetics Define a Complete Kinetic Model for Protein Arginine Methyltransferase 1.
    Hu H; Luo C; Zheng YG
    J Biol Chem; 2016 Dec; 291(52):26722-26738. PubMed ID: 27834681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectors and effects of arginine methylation.
    Wang Y; Bedford MT
    Biochem Soc Trans; 2023 Apr; 51(2):725-734. PubMed ID: 37013969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRMT1 expression is elevated in head and neck cancer and inhibition of protein arginine methylation by adenosine dialdehyde or PRMT1 knockdown downregulates proliferation and migration of oral cancer cells.
    Chuang CY; Chang CP; Lee YJ; Lin WL; Chang WW; Wu JS; Cheng YW; Lee H; Li C
    Oncol Rep; 2017 Aug; 38(2):1115-1123. PubMed ID: 28656289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gestational changes in PRMT1 expression of murine placentas.
    Sato A; Kim JD; Mizukami H; Nakashima M; Kako K; Ishida J; Itakura A; Takeda S; Fukamizu A
    Placenta; 2018 May; 65():47-54. PubMed ID: 29908641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein Arginine Methyltransferase Product Specificity Is Mediated by Distinct Active-site Architectures.
    Jain K; Warmack RA; Debler EW; Hadjikyriacou A; Stavropoulos P; Clarke SG
    J Biol Chem; 2016 Aug; 291(35):18299-308. PubMed ID: 27387499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of substrate modifications on the arginine dimethylation activities of PRMT1 and PRMT5.
    Fulton MD; Dang T; Brown T; Zheng YG
    Epigenetics; 2022 Jan; 17(1):1-18. PubMed ID: 33380261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein arginine methylation of SERBP1 by protein arginine methyltransferase 1 affects cytoplasmic/nuclear distribution.
    Lee YJ; Hsieh WY; Chen LY; Li C
    J Cell Biochem; 2012 Aug; 113(8):2721-8. PubMed ID: 22442049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginine methylation of BCL-2 antagonist of cell death (BAD) counteracts its phosphorylation and inactivation by Akt.
    Sakamaki J; Daitoku H; Ueno K; Hagiwara A; Yamagata K; Fukamizu A
    Proc Natl Acad Sci U S A; 2011 Apr; 108(15):6085-90. PubMed ID: 21444773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox Control of Protein Arginine Methyltransferase 1 (PRMT1) Activity.
    Morales Y; Nitzel DV; Price OM; Gui S; Li J; Qu J; Hevel JM
    J Biol Chem; 2015 Jun; 290(24):14915-26. PubMed ID: 25911106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.